Sponsor content
335 result(s) found, displaying 61 to 70
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules Budesonide Suspension for Inhalation 2ml: 0.5mg.
-
-
Australian public assessment report (AusPar)Lynparza (olaparib) has been approved for the treatment of BRCA-mutated HER2-negative high risk early breast cancer and metastatic castration-resistant prostate cancer.
-
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules budesonide 1 mg/2 mL.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules budesonide 0.5 mg/2 mL.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FELODIPINE AZN ER felodipine 2.5 mg extended release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FELODIPINE AZN ER felodipine 10 mg extended release tablet blister pack.